Has Rachel Hefner received payments from drug or device companies?

Yes. Drug and device makers reported $2,444 in general payments to Rachel Hefner across 149 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rachel Hefner did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rachel Hefner come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rachel Hefner

Family · Springfield, PANPI 1184261455

Payments from drug & device makers

$2,444in general payments, 2019–2025

Across 149 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$590
Boehringer Ingelheim$371
Novo Nordisk$263
Lilly USA, LLC$203
Teva Pharmaceuticals USA, Inc.$181
Sanofi-aventis U.S. LLC$112
plus $723 from 18 others

What the payments were for

Food & beverage$2,444100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	37	$590
Boehringer Ingelheim	22	$371
Novo Nordisk	16	$263
Lilly USA, LLC	14	$203
Teva Pharmaceuticals USA, Inc.	5	$181
Sanofi-aventis U.S. LLC	8	$112
Bayer	5	$81
Pfizer	5	$80
Biohaven Pharmaceuticals, Inc.	4	$72
Johnson & Johnson	4	$55
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$54
Amarin Pharma, Inc.	3	$47
Biogen	2	$44
Acerus Pharmaceuticals Corporation	3	$42
Kowa Pharmaceuticals America, Inc.	3	$40
Amgen	2	$37
Astellas Pharma US Inc	2	$31
Genentech USA, Inc.	2	$28
Clarus Therapeutics Inc.	2	$28
Eisai Inc.	2	$27
AstraZeneca	1	$16
Bausch Health US, LLC	1	$15
Vistapharm, Inc.	1	$14
Xeris Pharmaceuticals, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

UZEDY$124

How this compares

$2,444 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	17	$14,467
Rosuvastatin Calcium	17	$328
Atorvastatin Calcium	31	$326
Lisinopril	32	$312
Pantoprazole Sodium	11	$227
Metformin Hcl	24	$199
Montelukast Sodium	16	$181
Levothyroxine Sodium	16	$172
Hydrochlorothiazide	29	$165
Omeprazole	12	$140
Amlodipine Besylate	23	$131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Boehringer IngelheimJardiance	$371	$14,46717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.

Other family in Springfield

Karen SmithSpringfield$16K
Kathleen ScholzPittsburgh$397K
Shannon FitzgeraldAllison Park$370K
Stephanie HarshbargerCamp Hill$317K
Whitney BowlesFort Washington$253K
Kweilynn GreenePittsburgh$139K
Jessica LindenbergerPittsburgh$131K
Kami NestlerWilkes Barre$129K
Bethany ThomasPhiladelphia$126K
Margaret RosenzweigPittsburgh$89K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →